Sex differences in outcome after implantable cardioverter defibrillator implantation in nonischemic cardiomyopathy

American Heart Journal

Volumn 156, Issue 2, 2008, Pages 367-372

  Albert, Christine M ^a,f   Quigg, Rebecca ^b,f   Saba, Samir ^c,f   Estes III, N A Mark ^d,f   Shaechter, Andi ^b,f   Subacius, Haris ^b,f   Howard, Adam ^b,f   Levine, Joseph ^e,f   Kadish, Alan ^b,f  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e ST FRANCIS HOSPITAL   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOMYOPATHY; CLINICAL TRIAL; DEFIBRILLATOR; FEMALE; HEART ARRHYTHMIA; HEART DEATH; HEART DISEASE; HUMAN; IMPLANT; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NONISCHEMIC CARDIOMYOPATHY; PRIORITY JOURNAL; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

CARDIOMYOPATHIES; DEFIBRILLATORS, IMPLANTABLE; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; SEX FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 47849109482     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.02.026     Document Type: Article

References (24)

1. Buxton A.E., Lee K.L., Fisher J.D., et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 341 (1999) 1882-1890
2. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
3. Kadish A., Dyer A., Daubert J.P., et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350 (2004) 2151-2158
4. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
5. Kannel W.B., Wilson P.W., D'Agostino R.B., et al. Sudden coronary death in women. Am Heart J 136 (1998) 205-212
6. Adams Jr. K.F., Dunlap S.H., Sueta C.A., et al. Relation between gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol 28 (1996) 1781-1788
7. Adams Jr. K.F., Sueta C.A., Gheorghiade M., et al. Gender differences in survival in advanced heart failure. Insights from the FIRST study. Circulation 99 (1999) 1816-1821
8. Simon T., Mary-Krause M., Funck-Brentano C., et al. Sex differences in the prognosis of congestive heart failure: results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II). Circulation 103 (2001) 375-380
9. Saxon L.A., Bristow M.R., Boehmer J., et al. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial. Circulation 114 (2006) 2766-2772
10. Ellenbogen K.A., Levine J.H., Berger R.D., et al. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?. Circulation 113 (2006) 776-782
11. Kadish A., Quigg R., Schaechter A., et al. Defibrillators in nonischemic cardiomyopathy treatment evaluation. Pacing Clin Electrophysiol 23 (2000) 338-343
12. Zareba W., Moss A.J., Jackson Hall W., et al. Clinical course and implantable cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction. J Cardiovasc Electrophysiol 16 (2005) 1265-1270
13. Russo A.M., Stamato N.J., Lehmann M.H., et al. Influence of gender on arrhythmia characteristics and outcome in the Multicenter UnSustained Tachycardia Trial. J Cardiovasc Electrophysiol 15 (2004) 993-998
14. Lampert R., McPherson C.A., Clancy J.F., et al. Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators. J Am Coll Cardiol 43 (2004) 2293-2299
15. Singh J.P., Hall W.J., McNitt S., et al. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). J Am Coll Cardiol 46 (2005) 1712-1720
16. Saxon L.A., De Marco T., Schafer J., et al. Effects of long-term biventricular stimulation for resynchronization on echocardiographic measures of remodeling. Circulation 105 (2002) 1304-1310
17. Pires L.A., Sethuraman B., Guduguntla V.D., et al. Outcome of women versus men with ventricular tachyarrhythmias treated with the implantable cardioverter defibrillator. J Cardiovasc Electrophysiol 13 (2002) 563-568
18. Packer M., O'Connor C.M., Ghali J.K., et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. N Engl J Med 335 (1996) 1107-1114
19. Rathore S.S., Wang Y., and Krumholz H.M. Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med 347 (2002) 1403-1411
20. Anonymous. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353 (1999) 2001-2007
21. Cabell C.H., Trichon B.H., Velazquez E.J., et al. Importance of echocardiography in patients with severe nonischemic heart failure: the second Prospective Randomized Amlodipine Survival Evaluation (PRAISE-2) echocardiographic study. Am Heart J 147 (2004) 151-157
22. Curtis L.H., Al-Khatib S.M., Shea A.M., et al. Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death. JAMA 298 (2007) 1517-1524
23. Hernandez A.F., Fonarow G.C., Liang L., et al. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA 298 (2007) 1525-1532
24. Redberg R.F. Disparities in use of implantable cardioverter-defibrillators: moving beyond process measures to outcomes data. JAMA 298 (2007) 1564-1566